NASDAQ: SXTC - China SXT Pharmaceuticals, Inc.

Yield per half year: -67.46%
Dividend yield: 0.00%
Sector: Healthcare

Share chart China SXT Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands.

more details
The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2019-01-04
ISIN VGG2161P1163
Industry Personal Care Products
Sector Consumer Staples
Валюта usd
Валюта отчета usd
Сайт https://www.sxtchina.com
Цена ао 2.77
Change price per day: 0% (1.7)
Change price per week: -40.56% (2.86)
Change price per month: -35.11% (2.62)
Change price per 3 month: -45.87% (3.1408)
Change price per half year: -67.46% (5.224)
Change price per year: +44.07% (1.18)
Change price per 3 year: +14 682.61% (0.0115)
Change price per 5 year: +5 971.43% (0.028)
Change price per year to date: -33.59% (2.56)
All parameters

Underestimation

Title Value Grade
P/S 6.05 1
P/BV 0.8369 9
P/E 0 0
EV/EBITDA -0.9508 0
Total: 5

Efficiency

Title Value Grade
ROA, % -11.76 0
ROE, % -21.65 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.9229

Debt

Title Value Grade
Debt/EBITDA -1.13 10
Total: 8.2

Growth impulse

Title Value Grade
Yield Revenue, % -62.91 0
Yield Ebitda, % -151.11 0
Yield EPS, % -89.27 0
Total: 0
More

Institutions Volume Share, %
Citadel Advisors Llc 7654 0.05
UBS Group AG 6408 0.05
Acadian Asset Management. LLC 4202 0.03
TWO SIGMA SECURITIES, LLC 1999 0.01
Qube Research & Technologies Ltd 2 0



Head Job title Payment Year of birth
Mr. Feng Zhou Chairman of the Board & CEO 50k 1992 (33 years)
Mr. Xiaodong Pan Chief Financial Officer 50k 1978 (47 years)
Mr. Jun Zheng Executive Director N/A 1978 (47 years)

Address: China, Taizhou, 178 North Taidong Road - open in Google maps, open in Yandex maps
Website: https://www.sxtchina.com